MTI013
Product Specifications
Target
Opioid Receptor, SARS-CoV
Related Pathways
GPCR/G Protein, Endocrinology/Hormones, Neuroscience, Microbiology/Virology
Bioactivity
MTI013 is a selective inhibitor of SARS-CoV-2 nsp14 Mtase (IC50: 2.98 μM) and an antiviral agent (IC50: 10.33 μM in HCoV-229E infected Huh7 cells) . Additionally, MTI013 demonstrates synergistic antiviral effects when used in conjunction with the RdRp inhibitor SHEN26.
Smiles
O=C(C1=CC(CSC[C@H]2[C@H](O)[C@@H](O)[C@H](N3C(N=CN=C4N)C4N=C3)O2)=CC=C1)NC5=CC=CC=C5
Molecular Formula
C24H26N6O4S
Molecular Weight
494.57
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
orb2903817-01 20 µg
Recombinant Drosophila yakuba Protein wntless (wls)
Sign In for Pricing
View Details orb2903817-02 100 µg
Recombinant Drosophila yakuba Protein wntless (wls)
Sign In for Pricing
View Details 
NBP3-12045UV 0.1 mL
Rabbit Monoclonal MS4A4A Antibody (3F2) [DyLight 350]
Sign In for Pricing
View Details